Vohra Ishaan, Gopakumar Harishankar, Sharma Neil R, Puli Srinivas R
Department of Gastroenterology and Hepatology, University of Illinois College of Medicine at Peoria, Peoria, IL, USA.
Parkview Cancer Institute, Advanced Interventional Endoscopy & Endoscopic Oncology (IOSE) Division, GI Oncology Program, Fort Wayne, IN, USA.
Clin Endosc. 2025 Jan;58(1):53-62. doi: 10.5946/ce.2023.282. Epub 2024 Oct 10.
BACKGROUND/AIMS: Endoscopic vacuum-assisted closure (EVAC) is a novel technique used to repair esophageal perforation and leaks. Varying data have been reported on the overall success rate of EVAC. We aimed to conduct a meta-analysis of the available data on the clinical success rate of EVAC.
Electronic databases were searched for publications addressing the efficacy of EVAC in esophageal luminal defects. Pooling was conducted using both fixed and random-effects models. The overall clinical success of EVAC therapy was considered the primary outcome, whereas, overall complication rates, need for adjunct therapy, and mortality were considered secondary outcomes.
In total, 366 patients were included in the study. On pooled analysis, the mean age was 66 years with 68.32% of patients being men. Overall pooled clinical success rate of EVAC therapy was 87.95%. Upon subgroup analysis, the pooled clinical success rate of postsurgical anastomotic leak and transmural esophageal perforation were found to be 86.57% and 88.89%, respectively. The all-cause hospital mortality was 14% and 4.2% in patients with esophageal perforation and EVAC, respectively.
This study demonstrates that EVAC therapy has a high overall clinical success rate, with low mortality. EVAC therapy seems to be a promising procedure with excellent outcomes in patients with luminal esophageal defects.
背景/目的:内镜下真空辅助闭合术(EVAC)是一种用于修复食管穿孔和渗漏的新技术。关于EVAC的总体成功率,已有不同的数据报道。我们旨在对EVAC临床成功率的现有数据进行荟萃分析。
检索电子数据库,查找关于EVAC治疗食管腔内缺损疗效的出版物。使用固定效应模型和随机效应模型进行汇总分析。EVAC治疗的总体临床成功率被视为主要结局,而总体并发症发生率、辅助治疗需求和死亡率则被视为次要结局。
该研究共纳入366例患者。汇总分析显示,平均年龄为66岁,男性患者占68.32%。EVAC治疗的总体汇总临床成功率为87.95%。亚组分析发现,术后吻合口漏和全层食管穿孔的汇总临床成功率分别为86.57%和88.89%。食管穿孔患者和接受EVAC治疗患者的全因住院死亡率分别为14%和4.2%。
本研究表明,EVAC治疗具有较高的总体临床成功率和较低的死亡率。对于食管腔内缺损患者,EVAC治疗似乎是一种前景良好、疗效优异的治疗方法。